Study of an Investigational Drug for the Prevention of Thrombosis-related Events Following Hip Replacement Surgery (ADVANCE-3)

NCT00423319 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

5407

Enrollment

INDUSTRY

Sponsor class

Conditions

Deep Vein Thrombosis
Pulmonary Embolism

Interventions

DRUG: Enoxaparin
DRUG: Apixaban
DRUG: Enoxaparin-matching placebo
DRUG: Apixaban-matching placebo

Sponsor

Bristol-Myers Squibb